Cross Atlantic Angels
VC Fund
Cross Atlantic Angels is a US-based business angel group that invests in German startups with a path to US market entry.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cross Atlantic Angels invests in
Stages Cross Atlantic Angels invests in
Countries Cross Atlantic Angels invests in
Investment Focus
Industry
- Artificial Intelligence 4 (57%)
- Industrial 2 (29%)
- Health Care 2 (29%)
- Manufacturing 2 (29%)
- SaaS 1 (14%)
Stage
- Seed 3 (43%)
- Pre-Seed 2 (29%)
- Venture - Series Unknown 1 (14%)
Country
- Germany 3 (43%)
- United States 2 (29%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Nexxa.ai builds Multi-Agent Systems for the heavy industries the world relies on powered by a combination of computer use AI and AI tools like ml/computer vision. Tech companies have automated workflows for years—but industrial operations still rely on massive human labor forces to handle processes in fragmented systems. Human operatedmission-critical workflows in non-tech industries far exceed the number in tech which leads to a massive opportunity for automation. Cookie-cutter solutions & agent builders don’t solve the problem due to lack of technical expertise and custom tools in these industries. Nexxa specialized AI agents take over the work of entire teams in industrial operations. Our computer use agents integrate with legacy systems and execute complex processes in the existing infrastructure of our customers. We build proprietary computer vision models that augment existing computer use agents so that the models understand the custom software environments of our customers. | $9M / Seed / Jan 21, 2026 | |
|
|
Autopoiesis Sciences builds next-generation AI models designed to unlock transformative scientific breakthroughs across all critical research domains. The company's approach focuses on developing foundational reasoning capabilities that can autonomously drive discovery in areas where traditional AI has failed to deliver reliable results. | Pre-Seed / Jul 30, 2025 | |
|
|
Nexxa.ai builds Multi-Agent Systems for the heavy industries the world relies on powered by a combination of computer use AI and AI tools like ml/computer vision. Tech companies have automated workflows for years—but industrial operations still rely on massive human labor forces to handle processes in fragmented systems. Human operatedmission-critical workflows in non-tech industries far exceed the number in tech which leads to a massive opportunity for automation. Cookie-cutter solutions & agent builders don’t solve the problem due to lack of technical expertise and custom tools in these industries. Nexxa specialized AI agents take over the work of entire teams in industrial operations. Our computer use agents integrate with legacy systems and execute complex processes in the existing infrastructure of our customers. We build proprietary computer vision models that augment existing computer use agents so that the models understand the custom software environments of our customers. | $4.4M / Pre-Seed / Jul 21, 2025 | |
|
|
Assemblio – Plan your assembly in minutes, instead of weeksAssemblio supports customers from various industries in optimizing their assembly processes, reducing costs, and increasing productivity. Assemblio's mission is to revolutionize assembly planning using artificial intelligence, web technologies, and gamification techniques. Assembliostrives to automate work-intensive processes and improve the user experience in assembly. Assemblio GmbH was founded in 2022 as a spin-off of Stuttgart's Fraunhofer Institute for Manufacturing Engineering and Automation IPA. | $2.3M / Seed / Feb 28, 2024 | |
|
|
What is trackle?trackle is a fully integrated wearable system that helps women to identify their individual fertility window by tracking the body core temperature.What makes trackle relevant right now? With increasing age, the likelihood of getting pregnant lowers rapidly. Women who want to have kids lately need to know exactly about theirfertility window in order to increase chances of getting pregnant. Same applies for women who want to avoid pregnancy without hormone treatments. For them, it is important to know when their ovulation happens in order to choose the right means for contraception. Knowing the individual fertility window becomes more and more relevant to a growing group of women. What is the problem trackle is solving? Identifying that rise of the body core temperature is challenging – especially as you need to avoid all noise that influences body core temperature. That is why women measure core temperature first thing in the morning before having moved. Thus, they operate with approximate values they enter into old fashioned scale paper graphs.How does trackle work?The wearable sensor is worn vaginal overnight and determines the core temperature every hour. It regularly transmits the values via a wireless connection to a gateway, which passes it on to a server. On the server it is processed and provided for the user’s mobile app. Thus, the one and only relevant value can be identified easily: it is the lowest value measured overnight. In comparison to the other values taken the nights before, ovulation can be identified very securely and with our mature machine learning system, we are able to predict the exact timing of ovulation closer the more data we receive. The gateway serves as a safe and discrete storage box for the sensor also. | Venture - Series Unknown / Jan 18, 2024 | |
|
|
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data. | $3.7M / Seed | |
|
|
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data. | $3.7M / Seed |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cross Atlantic Angels invest in?
Cross Atlantic Angels invests primarily in Artificial Intelligence, Industrial and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cross Atlantic Angels last invest?
The most recent investment recorded for Cross Atlantic Angels closed in Jan 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!